These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 14993330)

  • 21. A combined approach for the classification of G protein-coupled receptors and its application to detect GPCR splice variants.
    Eo HS; Choi JP; Noh SJ; Hur CG; Kim W
    Comput Biol Chem; 2007 Aug; 31(4):246-56. PubMed ID: 17631418
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Agonist-induced conformational changes in bovine rhodopsin: insight into activation of G-protein-coupled receptors.
    Bhattacharya S; Hall SE; Vaidehi N
    J Mol Biol; 2008 Oct; 382(2):539-55. PubMed ID: 18638482
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Structural diversity of G protein-coupled receptors and significance for drug discovery.
    Lagerström MC; Schiöth HB
    Nat Rev Drug Discov; 2008 Apr; 7(4):339-57. PubMed ID: 18382464
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complexing receptor pharmacology: modulation of family B G protein-coupled receptor function by RAMPs.
    Sexton PM; Morfis M; Tilakaratne N; Hay DL; Udawela M; Christopoulos G; Christopoulos A
    Ann N Y Acad Sci; 2006 Jul; 1070():90-104. PubMed ID: 16888151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relaxin-3, INSL5, and their receptors.
    Liu C; Lovenberg TW
    Results Probl Cell Differ; 2008; 46():213-37. PubMed ID: 18236022
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The opioid ligand binding of human mu-opioid receptor is modulated by novel splice variants of the receptor.
    Choi HS; Kim CS; Hwang CK; Song KY; Wang W; Qiu Y; Law PY; Wei LN; Loh HH
    Biochem Biophys Res Commun; 2006 May; 343(4):1132-40. PubMed ID: 16580639
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular biology of 5-HT receptors.
    Hannon J; Hoyer D
    Behav Brain Res; 2008 Dec; 195(1):198-213. PubMed ID: 18571247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virtual screen for ligands of orphan G protein-coupled receptors.
    Bock JR; Gough DA
    J Chem Inf Model; 2005; 45(5):1402-14. PubMed ID: 16180917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clathrin-dependent mechanisms of G protein-coupled receptor endocytosis.
    Wolfe BL; Trejo J
    Traffic; 2007 May; 8(5):462-70. PubMed ID: 17376169
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Physiological relevance of GPCR oligomerization and its impact on drug discovery.
    Panetta R; Greenwood MT
    Drug Discov Today; 2008 Dec; 13(23-24):1059-66. PubMed ID: 18824244
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Structural plasticity in G-protein coupled receptors as demonstrated by the allosteric actions of homocysteine and computer-assisted analysis of disordered domains.
    Agnati LF; Leo G; Genedani S; Andreoli N; Marcellino D; Woods A; Piron L; Guidolin D; Fuxe K
    Brain Res Rev; 2008 Aug; 58(2):459-74. PubMed ID: 18022243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel roles for arrestins in the post-endocytic trafficking of G protein-coupled receptors.
    Prossnitz ER
    Life Sci; 2004 Jul; 75(8):893-9. PubMed ID: 15193949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prediction of the coupling specificity of GPCRs to four families of G-proteins using hidden Markov models and artificial neural networks.
    Sgourakis NG; Bagos PG; Hamodrakas SJ
    Bioinformatics; 2005 Nov; 21(22):4101-6. PubMed ID: 16174684
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulating G-protein-coupled receptors: from traditional pharmacology to allosterics.
    Gilchrist A
    Trends Pharmacol Sci; 2007 Aug; 28(8):431-7. PubMed ID: 17644194
    [TBL] [Abstract][Full Text] [Related]  

  • 35. When a G protein-coupled receptor does not couple to a G protein.
    Sun Y; McGarrigle D; Huang XY
    Mol Biosyst; 2007 Dec; 3(12):849-54. PubMed ID: 18000562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacogenomics of G protein-coupled receptor signaling: insights from health and disease.
    Thompson MD; Cole DE; Jose PA
    Methods Mol Biol; 2008; 448():77-107. PubMed ID: 18370232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. GPCR-GIP networks: a first step in the discovery of new therapeutic drugs?
    Bockaert J; Dumuis A; Fagni L; Marin P
    Curr Opin Drug Discov Devel; 2004 Sep; 7(5):649-57. PubMed ID: 15503867
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The apparent cooperativity of some GPCRs does not necessarily imply dimerization.
    Chabre M; Deterre P; Antonny B
    Trends Pharmacol Sci; 2009 Apr; 30(4):182-7. PubMed ID: 19269046
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A constitutively active GPCR retains its G protein specificity and the ability to form dimers.
    Ladds G; Davis K; Das A; Davey J
    Mol Microbiol; 2005 Jan; 55(2):482-97. PubMed ID: 15659165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. G-protein-coupled receptors, cholesterol and palmitoylation: facts about fats.
    Chini B; Parenti M
    J Mol Endocrinol; 2009 May; 42(5):371-9. PubMed ID: 19131499
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.